South Korea
· Delayed Price · Currency is KRW Milae Bioresources Statistics
Total Valuation
Milae Bioresources has a market cap or net worth of KRW 86.56 billion. The enterprise value is 67.81 billion.
| Market Cap | 86.56B |
| Enterprise Value | 67.81B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Milae Bioresources has 19.50 million shares outstanding. The number of shares has increased by 2.62% in one year.
| Shares Outstanding | 19.50M |
| Shares Change (YoY) | +2.62% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 53.08% |
| Owned by Institutions (%) | 4.66% |
| Float | 8.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.41 |
| PB Ratio | 1.96 |
| P/FCF Ratio | 18,505.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 124.18, with an EV/FCF ratio of 14,496.00.
| EV / Earnings | -1,188.56 |
| EV / Sales | 1.11 |
| EV / EBITDA | 124.18 |
| EV / EBIT | n/a |
| EV / FCF | 14,496.00 |
Financial Position
The company has a current ratio of 4.28, with a Debt / Equity ratio of 0.12.
| Current Ratio | 4.28 |
| Quick Ratio | 3.69 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 9.62 |
| Debt / FCF | 1,123.42 |
| Interest Coverage | -1.78 |
Financial Efficiency
Return on equity (ROE) is -0.32% and return on invested capital (ROIC) is -0.56%.
| Return on Equity (ROE) | -0.32% |
| Return on Assets (ROA) | -0.52% |
| Return on Capital (ROIC) | -0.56% |
| Revenue Per Employee | 1.30B |
| Profits Per Employee | -1.21M |
| Employee Count | 47 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 9.62 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.26% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -9.26% |
| 50-Day Moving Average | 4,414.30 |
| 200-Day Moving Average | 4,852.55 |
| Relative Strength Index (RSI) | 49.94 |
| Average Volume (20 Days) | 2,541,646 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Milae Bioresources had revenue of KRW 61.17 billion and -57.05 million in losses. Loss per share was -2.93.
| Revenue | 61.17B |
| Gross Profit | 7.81B |
| Operating Income | -474.29M |
| Pretax Income | -206.97M |
| Net Income | -57.05M |
| EBITDA | 546.02M |
| EBIT | -474.29M |
| Loss Per Share | -2.93 |
Balance Sheet
The company has 23.97 billion in cash and 5.25 billion in debt, giving a net cash position of 18.71 billion or 959.88 per share.
| Cash & Cash Equivalents | 23.97B |
| Total Debt | 5.25B |
| Net Cash | 18.71B |
| Net Cash Per Share | 959.88 |
| Equity (Book Value) | 44.09B |
| Book Value Per Share | 2,263.51 |
| Working Capital | 30.62B |
Cash Flow
In the last 12 months, operating cash flow was 249.35 million and capital expenditures -244.67 million, giving a free cash flow of 4.68 million.
| Operating Cash Flow | 249.35M |
| Capital Expenditures | -244.67M |
| Free Cash Flow | 4.68M |
| FCF Per Share | 0.24 |
Margins
Gross margin is 12.76%, with operating and profit margins of -0.78% and -0.09%.
| Gross Margin | 12.76% |
| Operating Margin | -0.78% |
| Pretax Margin | -0.34% |
| Profit Margin | -0.09% |
| EBITDA Margin | 0.89% |
| EBIT Margin | -0.78% |
| FCF Margin | 0.01% |
Dividends & Yields
Milae Bioresources does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.62% |
| Shareholder Yield | -2.62% |
| Earnings Yield | -0.07% |
| FCF Yield | 0.01% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Milae Bioresources has an Altman Z-Score of 8.4.
| Altman Z-Score | 8.4 |
| Piotroski F-Score | n/a |